COVIDH Technologies Shuts Trading Window April 1 Ahead of Q4 Results

SEBIEXCHANGE
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
COVIDH Technologies Shuts Trading Window April 1 Ahead of Q4 Results
Overview

COVIDH Technologies Limited will close its trading window for designated persons starting April 1, 2026. This is in line with SEBI (Prohibition of Insider Trading) Regulations, 2018, as the company prepares to announce its audited financial results for the quarter ending March 31, 2026. The window will reopen 48 hours after the results are made public.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

COVIDH Technologies Halts Insider Trading Ahead of Q4 Results

April 1, 2026, marks the start of the trading window closure for designated persons at COVIDH Technologies Limited, ahead of the company's audited financial results for the quarter ended March 31, 2026.

Announcement Details

COVIDH Technologies Limited has announced the closure of its trading window for designated employees and directors, effective April 01, 2026. This measure adheres strictly to SEBI (Prohibition of Insider Trading) Regulations, 2018, aiming to prevent any potential misuse of unpublished price-sensitive information. The window is set to reopen 48 hours after the company announces its audited financial results for the quarter ending March 31, 2026 (Q4 FY26).

Why This Matters

These trading window closures are a key component of corporate governance, ensuring insiders do not trade on material non-public information. This safeguards market integrity and promotes fair trading practices. The closure signals the company's commitment to regulatory compliance and transparency as it prepares to release its year-end financial results.

Regulatory Backstory

COVIDH Technologies Limited, an IT/ITES firm founded in 1993, has a history of navigating regulatory requirements, including past SEBI actions. In 2022, SEBI fined three individuals a total of Rs 60 lakh for stock price manipulation and failing to comply with summons related to the company's shares in February 2017. Previously, in 2018, SEBI fined a former promoter Rs 6 lakh for disclosure lapses concerning shareholding changes, violating insider trading and takeover norms. These past events highlight the importance of strict adherence to SEBI regulations, particularly concerning insider trading.

Impact on Designated Persons

This closure means designated persons, including directors and key management, are prohibited from trading the company's shares starting April 1, 2026. The restriction will last until 48 hours after the official announcement of the Q4 FY26 financial results. The company is expected to soon announce the date of its Board Meeting to approve these audited financial results for the quarter and fiscal year ended March 31, 2026.

Potential Risks and Oversight

While the trading window closure aims to prevent insider trading, the company's history of past SEBI actions regarding market manipulation and disclosure lapses means regulatory scrutiny is likely to remain high. Investors are advised to watch for any further announcements concerning compliance or corporate actions.

Industry Standard Practice

Trading window closures are a standard and mandatory practice for all listed companies in India. Peers in the IT sector, such as Tata Elxsi and Tata Technologies, follow similar procedures to ensure a level playing field and comply with SEBI's (Prohibition of Insider Trading) Regulations, 2018. The duration and specific dates vary based on each company's financial calendar and results announcement schedules.

What to Track Next

Investors should track the upcoming announcement of the Board Meeting date for approving Q4 FY26 results, the official release of these financial results, and any further updates on corporate activities, including the proposed acquisition of iSERA Biological Private Limited.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.